CPL @1112 (55.4%) on 19-jul-2018 [ "drug is manufactured by _" "educational grant from _" "milestone payment from _" "Japanese subsidiary of _" "unrestricted educational grant from _" "unrestricted grant from _" "pharmaceutical companies , such as _" "clinical trial was sponsored by _" "drug companies like _" "educational grants from _" "pharmaceutical companies including _" "giants including _" "trial was sponsored by _" "registered product of _" "worldwide rights from _" "business unit of _" "study was sponsored by _" "new drug from _" "exclusive license agreement with _" "drug manufactured by _" "trial was supported by _" "registered brand name of _" ] using novartis_pharma_ag
SEAL @241 (50.9%) on 22-apr-2011 [ 1 ] using novartis_pharma_ag
relations
NELL has only weak evidence for items listed in grey